How to stop hair loss on Mounjaro if you're a woman

Three months in and your hairbrush tells a different story

You started Mounjaro, the weight began to shift, and then (around month two or three) you noticed more hair in the shower drain. It's a surprisingly common moment for women on this treatment, and it tends to land as a shock precisely because the medicine seems to be working well.

The condition is called telogen effluvium. When the body experiences a significant physical stress (and meaningful calorie restriction qualifies) a larger-than-normal proportion of hair follicles move into the telogen (resting) phase simultaneously. Six to twelve weeks later, those hairs shed. The timing is what makes it feel alarming: the shedding arrives just as your confidence in the treatment is growing.

Mounjaro itself (tirzepatide) is not thought to be directly toxic to hair follicles. The NHS medicines information for tirzepatide lists hair loss among reported side effects, acknowledging the association without attributing it to the molecule rather than the weight-loss process. The broader picture, documented across GLP-1 medicines, consistently points to nutritional deficit as the driver. Understanding that distinction matters, because it changes what you do about it, and it means stopping Mounjaro is rarely the answer.

The practical steps that can slow and stop the shedding

Protein is where to start. Hair is largely keratin, and keratin is protein. When daily intake drops sharply (as appetite suppression on Mounjaro can cause) the body deprioritises hair growth in favour of more critical functions. Women on GLP-1 medicines who eat fewer than roughly 60–80g of protein a day are at noticeably higher risk of prolonged shedding, though individual needs vary and a registered dietitian can give you a figure calibrated to your weight and activity level.

Practical ways to protect protein intake include building every meal around a protein source first (eggs, Greek yoghurt, fish, legumes, chicken), using a protein supplement if solid food feels unappealing during the nausea phase, and prioritising protein even on days when overall appetite is very low. Our page on the general approach to stopping hair loss on Mounjaro covers nutritional strategies in more detail.

Iron, ferritin, zinc and vitamin D deficiencies can compound follicle stress independently of protein. A simple blood test through your GP can identify whether any of these are a factor; low ferritin is a frequently overlooked contributor to female hair loss. Addressing a deficiency won't reverse shedding overnight (hair cycles are slow) but it removes a compounding variable.

Scalp care matters less than nutrition, but it is not irrelevant. Gentle, sulphate-free shampoos reduce mechanical stress on fragile shafts, and some women find caffeine-based or ketoconazole-based products helpful, though the evidence for these in telogen effluvium specifically is limited. Our page on shampoo choices for Mounjaro-related hair loss looks at what the data actually says.

Strength training alongside treatment serves double duty: it preserves lean muscle mass (which supports metabolism) and appears to reduce the severity of nutrition-related hair loss by improving overall nutrient partitioning. If you have not already introduced resistance exercise, it is worth discussing with your prescriber.

When to get medical help rather than waiting it out

Most telogen effluvium resolves within three to six months of the trigger, in this case, once your body adapts to the new eating pattern and protein intake stabilises. But not all hair loss during Mounjaro treatment fits that pattern, and some presentations need a GP assessment rather than dietary tweaks.

Seek medical advice promptly if you notice: patchy or localised loss (rather than diffuse thinning across the whole scalp), a visibly inflamed or itchy scalp, eyebrow or eyelash involvement, or shedding that is accelerating rather than plateauing after four to five months. These features may indicate a separate underlying condition (alopecia areata, thyroid dysfunction, or scalp dermatitis) that happens to have surfaced during your treatment period and needs its own diagnosis.

If you are concerned about hair loss as a side effect of Mounjaro, you can report it through the MHRA Yellow Card scheme. This is the UK's system for gathering real-world safety data on medicines, and your report contributes to the evidence base even if your individual case is not followed up directly. You can also raise it with your prescriber at your next clinical review, our prescribers discuss side effects including hair changes as a standard part of the consultation, and no concern is too minor to mention.

Women who started Mounjaro and are worried about hair loss often ask whether they should pause or reduce their dose. In most cases the answer is no (interrupting treatment resets progress and does not clearly accelerate hair recovery) but that decision belongs to your prescriber, who can weigh your full clinical picture. You can read about Mounjaro-related hair loss in women more broadly, including what the available patient data shows, or explore the full side-effect profile of Mounjaro to put this in context alongside the more common GI effects.

One practical note: the months when shedding tends to peak (around three to five months into treatment) can coincide with the period when many people are thinking about their next repeat order. There is never a bad time to raise concerns with your clinical team. Our prescribers are available seven days a week for aftercare questions, so you do not need to wait for a scheduled review to flag something that is worrying you. If you have not yet started treatment and want to understand the full side-effect picture before deciding, starting a free consultation is the natural first step, suitability and side effects are covered as part of that conversation.

For a wider view of tirzepatide including how it works and what the clinical trials showed, the Mounjaro overview page is the place to start. If cost is a factor in your thinking, Mounjaro pricing in the UK explains what private treatment typically includes.